Logo image of ALDX

ALDEYRA THERAPEUTICS INC (ALDX) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:ALDX - US01438T1060 - Common Stock

5.24 USD
-0.24 (-4.38%)
Last: 12/1/2025, 8:00:00 PM
5.26 USD
+0.02 (+0.38%)
After Hours: 12/1/2025, 8:00:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
ALDX revenue by date.ALDX revenue by date.
N/AN/A
63.48%
N/A
59.94%
N/A
75.68%
N/A
34.13%
N/A
13.83%
N/A
12.55%
N/A
-2.39%
EBITDA
YoY % growth
ALDX ebitda by date.ALDX ebitda by date.
-7.27M-11.97M
-64.65%
-18.66M
-55.89%
-22.45M
-20.31%
-39.63M
-76.53%
-56.4M
-42.32%
-34.61M
38.63%
-55.96M
-61.69%
-62.42M
-11.54%
-42.531M
31.86%
-59.867M
-40.76%
N/A
8.33%
N/A
72.06%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ALDX ebit by date.ALDX ebit by date.
-7.27M-11.99M
-64.92%
-18.7M
-55.96%
-22.49M
-20.27%
-39.7M
-76.52%
-56.5M
-42.32%
-34.67M
38.64%
-56.22M
-62.16%
-62.68M
-11.49%
-42.794M
31.73%
-60.117M
-40.48%
N/A
47.65%
N/A
-23.83%
N/A
157.99%
N/A
122.78%
N/A
56.99%
N/A
19.62%
N/A
16.84%
N/A
-7.66%
Operating Margin
ALDX operating margin by date.ALDX operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
ALDX eps by date.ALDX eps by date.
N/A-1.40
37.80%
-1.67
-19.29%
-1.40
16.17%
-1.90
-35.71%
-2.23
-17.37%
-1.12
49.78%
-1.07
4.36%
-1.06
1.04%
-0.64
39.62%
-0.94
-46.88%
N/A
49.18%
N/A
-21.18%
N/A
162.26%
N/A
122.17%
N/A
59.24%
N/A
-1.60%
N/A
-2.44%
N/A
-2.50%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.17
38.04%
-0.09
46.00%
-0.15
4.38%
-0.13
-2.00%
-0.27
-58.54%
Revenue
Q2Q % growth
24.735M5.1MN/A
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
11.554M
169.70%
-9.471M
9.18%
-9.776M
3.86%
-5.503M
31.22%
N/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.13
48.00%
-0.250.1247.98%
Q2 2025
Q2Q % growth
-0.16
42.86%
-0.250.0935.53%
Q1 2025
Q2Q % growth
-0.17
-21.43%
-0.290.1240.48%
Q4 2024
Q2Q % growth
-0.27
-237.50%
-0.23-0.04-17.52%
Q3 2024
Q2Q % growth
-0.25
-78.57%
-0.250.000.77%
Q2 2024
Q2Q % growth
-0.28
-86.67%
-0.14-0.14-93.66%
Q1 2024
Q2Q % growth
-0.14
48.15%
-0.11-0.03-24.07%
Q4 2023
Q2Q % growth
-0.08
63.64%
-0.140.0644.08%
Q3 2023
Q2Q % growth
-0.14
44.00%
-0.240.1042.43%
Q2 2023
Q2Q % growth
-0.15
50.00%
-0.320.1752.70%
Q1 2023
Q2Q % growth
-0.27
6.90%
-0.300.039.21%
Q4 2022
Q2Q % growth
-0.22
18.86%
-0.320.1031.12%
Q3 2022
Q2Q % growth
-0.25
7.41%
-0.350.1028.75%
Q2 2022
Q2Q % growth
-0.30
-7.14%
-0.320.025.35%
Q1 2022
Q2Q % growth
-0.29
-16.00%
-0.320.039.80%
Q4 2021
Q2Q % growth
-0.27
9.62%
-0.290.026.18%
Q3 2021
Q2Q % growth
-0.27
-17.39%
-0.270.00-0.78%
Q2 2021
Q2Q % growth
-0.28
-12.00%
-0.25-0.03-13.49%
Q1 2021
Q2Q % growth
-0.25
26.47%
-0.270.028.32%
Q4 2020
Q2Q % growth
-0.30
36.17%
-0.29-0.01-3.85%
Q3 2020
Q2Q % growth
-0.23
66.67%
-0.280.0517.78%
Q2 2020
Q2Q % growth
-0.25
48.98%
-0.350.1028.16%
Q1 2020
Q2Q % growth
-0.34
41.38%
-0.490.1530.12%
Q4 2019
Q2Q % growth
-0.47 -0.730.2635.67%
Q3 2019
Q2Q % growth
-0.69 -0.56-0.13-23.03%
Q2 2019
Q2Q % growth
-0.49 -0.500.011.12%
Q1 2019
Q2Q % growth
-0.58 -0.44-0.14-33.08%
ALDX Yearly EPS VS EstimatesALDX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 1 -1 -2
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
-816K816K100.00%
Q1 2024
Q2Q % growth
2.04M-2.04M-100.00%
Q4 2023
Q2Q % growth
1.894M-1.894M-100.00%
ALDX Yearly Revenue VS EstimatesALDX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2023 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS35.43% 35.43% 0% 0%
Revenue0% 0% 0% -12.53%